Anglo-French Drugs & Industries Limited, a active public limited company, was established on 01 February 1923 in Bangalore North, Karnataka, India. Engaging in pharmaceutical retailers & distributors within the manufacturing sector, it holds CIN: L24230MH1923PLC463682. Registered under ROC Roc Bangalore. it is listed. It has an authorized capital of ₹2.00 Cr and a paid-up capital of ₹1.13 Cr.
Formerly known as The Anglo-French Drug Company (Eastern) Limited. It upholds a compliant status. In 2023, it reported revenue of ₹110.10 Cr and a net worth of ₹208.84 Cr. Employing 252 professional, Its leadership includes Srinivasan Krishnan (Additional Director), Nirbhay Abhay Kanoria (Managing Director), Uddhav Abhay Kanoria (Managing Director). Past directors included Pauly Sukumar Nuthakki, Ashok Kumar Roy, Neha Rajen Gada. It holds ₹45.15 Cr open charges and ₹82.21 Cr settled loans. Its latest AGM occurred on 11 August 2025, with the balance sheet filed on 31 March 2025. It is based at Plot No.4, Phase Ii, Peenya Industrial Area, Peenya, Bangalore North, Karnataka, 560058.
L24230MH1923PLC463682
010205
01 February 1923
₹2.00 Cr
₹1.13 Cr
Roc Bangalore
Listed
Active
Explore comprehensive insights into Anglo-French Drugs & Industries Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Srinivasan Krishnan | Additional Director | 12 Feb 2024 | Current |
| Nirbhay Abhay Kanoria | Managing Director | 01 Feb 2017 | Current |
| Uddhav Abhay Kanoria | Managing Director | 10 Aug 2006 | Current |
| Rani Shokeen | Director | 28 May 2024 | Current |
| Pradeep Vasantrao Joshi | Additional Director | 12 Feb 2024 | Current |
| Abhay Kanoria | Director | 01 Mar 1997 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Nominee Director | 29 Jun 2018 | Past |
| Pramod Abcsdd | Additional Director | 24 Aug 2012 | Past |
| Pramod Abcsdd | Additional Director | 26 Sep 2016 | Past |
| Pramod Abcsdd | Director | 16 May 2008 | Past |
| Pramod Abcsdd | Director | 12 Aug 2024 | Past |
| Pramod Abcsdd | Nominee Director | 09 May 2023 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Anglo-French Drugs & Industries's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹451,549,000.00
₹822,122,390.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Apr 2025 | Standard Chartered Bank | ₹15.00 Cr | Open |
| 11 Dec 2024 | Hdfc Bank Limited | ₹1.55 M | Open |
| 12 Aug 2024 | Hdfc Bank Limited | ₹30.00 Cr | Open |
| 18 Jul 2021 | Hdfc Bank Limited | ₹7.00 M | Satisfied |
| 20 May 2021 | Yes Bank Limited | ₹1.20 Cr | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Anglo-French Drugs & Industries, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Anglo-French Drugs & Industries, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Anglo-French Drugs & Industries's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Anglo-French Drugs & Industries Limited last Annual general meeting of members was held on 11 Aug 2025 as per latest MCA records. was completed.
Progress on Ganesh Ramgopalji Pallod was appointed as a Additional Director was appointed as a Additional Director on 11 Aug 2025 & has been associated with this company since 5 months 8 days . was documented.
A charge registered on 07 Feb 2017 via Charge ID 100095424 with Yes Bank Limited was fully satisfied on 24 Jun 2025. was recorded as a recent event.
The activity A charge with Standard Chartered Bank amounted to Rs. 15.00 Cr with Charge ID 101088456 was registered on 21 Apr 2025. was completed.
The activity Anglo-French Drugs & Industries Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore. was completed.
A charge registered on 23 Sep 2019 via Charge ID 100293428 with Axis Bank Limited was fully satisfied on 13 Jan 2025. was recorded as a recent event.
The product has received approval from Drug Control Department Anglo-French Drugs & Industries has launched a new product AFD-NP in the neuropathic pain segment. AFD-NP is a combination of Nortrip.
The CIN of Anglo-French Drugs & Industries Limited is L24230MH1923PLC463682.
Anglo-French Drugs & Industries Limited is headquartered at Plot No.4, Phase Ii, Peenya Industrial Area, Peenya, Bangalore North, Karnataka, 560058.
Anglo-French Drugs & Industries Limited was incorporated on 01 February 1923.
The current directors of Anglo-French Drugs & Industries Limited are
The primary industry of Anglo-French Drugs & Industries Limited is Manufacturing.
Anglo-French Drugs & Industries Limited is listed.
The authorized capital of Anglo-French Drugs & Industries Limited is ₹2.00 Cr, and the paid-up capital is ₹1.13 Cr.
The compliance status of Anglo-French Drugs & Industries Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX